Filing Details
- Accession Number:
- 0001415889-23-013116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-08 16:02:43
- Reporting Period:
- 2023-09-06
- Accepted Time:
- 2023-09-08 16:02:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1918147 | Alethia Young | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-06 | 7,000 | $27.85 | 16,067 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-09-06 | 7,000 | $39.90 | 9,067 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-09-06 | 4,666 | $27.85 | 13,733 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-09-06 | 4,666 | $39.79 | 9,067 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-09-06 | 7,000 | $27.85 | 7,000 | $27.85 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-09-06 | 4,666 | $27.85 | 4,666 | $27.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2032-06-08 | No | 4 | M | Direct | |
| 7,334 | 2032-06-08 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $39.42 | 2033-01-04 | 10,000 | 10,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2033-01-04 | 10,000 | 10,000 | Direct |
Footnotes
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Currently exercisable.
- This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022
- This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.
Billionaire Hedge Funds
